[Renal hemodynamics and its correlation with the Child-Pugh stage in cirrhotic patients and their controls]

Eric López Méndez1, Lourdes Avila Escobedo, Ignacio Guerrero Hernández

  • 1Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D.F. ericlopezmendez@yahoo.com.mx

Insights

Cirrhotic patients show increased renal artery resistance and pulsatility index, indicating reduced blood flow. Doppler ultrasound effectively assesses these hemodynamic changes, correlating well with disease severity (Child-Pugh class).

Area of Science:

  • Nephrology
  • Hepatology
  • Radiology

Background:

  • Portal hypertension in cirrhosis leads to splanchnic vasodilation and renal vasoconstriction.
  • Understanding renal hemodynamic changes is crucial for managing cirrhotic patients.

Purpose of the Study:

  • To measure renal artery pulsatility and resistance indices in cirrhotic patients across Child-Pugh classes (A, B, C).
  • To compare these indices with those of healthy controls.
  • To evaluate Doppler ultrasound's utility in assessing renal hemodynamic alterations in cirrhosis.

Main Methods:

  • Doppler spectral analysis was used to measure resistance index (RI) and pulsatility index (PI) in segmental and arcuate renal arteries.
  • Thirty cirrhotic patients (10 each of Child-Pugh A, B, C) and 10 healthy controls were included.
  • RI and PI calculations were performed using standard Doppler ultrasound techniques.

Main Results:

  • Both RI and PI were significantly higher in cirrhotic patients compared to controls, indicating diminished renal blood flow.
  • Pulsatility index showed significant differences across all Child-Pugh classes.
  • Resistance index showed a significant difference between Child-Pugh B and C classes.

Conclusions:

  • Doppler ultrasound is a valuable non-invasive tool for evaluating renal hemodynamic changes in cirrhosis.
  • A strong correlation exists between Child-Pugh class and the pulsatility index.
  • These findings highlight the impact of cirrhosis severity on renal vascular function.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...